REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

General Biologicals Corp. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: General Biologicals Corp. Profile Updated: February 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

General Biologicals Corporation (GBC) develops, manufactures, and delivers innovated diagnostic kits. Founded in 1984, GBC is a global leader in providing a spectrum of technology platform from diagnostics equipment in RIA, ELISA, Point-of-Care, and Real-Time PCR to a Sequential Vertical Technology in Hybridoma Techniques, Cell Culture, Genetic Engineering, Protein Purification, and Peptide Synthesis. GBC is certified as IVD Class-3 cGMP and distributing products in more than 50 countries worldwide.

Headquarters
6,Innovation First Road, Science-Based Park
Hsinchu City; Hsinchu City;

Contact Details: Purchase the General Biologicals Corp. report to view the information.

Website: http://www.gbc.com.tw

Basic Information
Total Employees:
Purchase the General Biologicals Corp. report to view the information.
Outstanding Shares:
Purchase the General Biologicals Corp. report to view the information.
Financial Auditors:
Purchase the General Biologicals Corp. report to view the information.
Incorporation Date:
June 11, 1984
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
19.73%
Purchase this report to view the information.
13.41%
Purchase this report to view the information.
0.66%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Gb Holdings Limited (Samoa)
100%
Gb(China) Holding Limited (Samoa)
100%
Pacgen Life Science Corporation (Canada)
91.85%
Company Performance
Financial values in the chart are available after General Biologicals Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-40.96%▼
Total operating revenue
-40.96%▼
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
17.1%▲
Total equity
-21%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
0.72%▲
Quick Ratio
-4.27%▼
Cash Ratio
-3.17%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo